Objective: The current study discusses the relationship between sleep apnea-hypopnea syndrome (OSAHS) and liver fibrosis by determining the level of plasma hyaluronic acid (HA), procollagen III (PIII), collagen IV (IVC), and laminin (LN) in OSAHS patients and non-OSAHS patients with obesity and normal body weight.
Introduction
The main symptom of obstructive sleep apneahypopnea syndrome (OSAHS) is recurrent upper airway collapse during sleep, which causes snoring, frequent apnea and hypopnea, recurrent nocturnal hyoxemia and hypercapnia, and disordered sleep structure. OSAHS can involve multiple systems and cause damage to multiple organs, and it constitutes an independent risk factor to cardiovascular and 
Subjects and methods

Subjects of study
Results
Basic information has been listed in Table 1 . Among all groups tested, age had no statistical significance after one-way analysis of variance (P>0.05). Gender had no statistical significance on c 2 testing (P>0.05).
Based on BMI, it was shown that among obese and normoweight patients, the levels of HA, PIII, IVC, and LN were higher than the non-OSAHS patients (P value <0.05).
Based upon AHI, it was shown that the levels of HA, PIII, IVC, and LN in the obese patients were higher than the nonobese patients (P<0.05). The levels of HA, PIII, IVC, and LN were higher in the obese OSAHS patients than the other 3 groups (P<0.05).
Results of correlation analysis between the levels of HA, PIII, IVC and LN in OSAHS patients, BMI and sleep monitoring indicators are listed in Table 2 . Relationship between obstructive sleep apnea-hypopnea syndrome (OSAHS) and liver fibrosis 
Discussion
OSAHS is closely associated with metabolic syndrome (MS).
Intermittent hypoxia, hypercapnia, sleep deprivation, and importance in establishing a diagnosis [6, 7] .
The levels of serum HA, PIII, IVC, and LN in the obese patients were higher than the non-obese patients amongst OSAHS and non-OSAHS patients (P value <0.05), and the levels of serum HA, PIII, IVC, and LN had a positive correlation with BMI.
Whether obese or normoweight, the levels of serum HA, PIII, IVC, and LN in OSAHS patients were higher than non-OSAHS patients, and the levels of serum HA, PIII, IVC, and LN in OSAHS patients had a positive correlation with AHI and a negative correlation with the lowest blood oxygen saturation and the average blood oxygen saturation, which indicated that OSAHS might cause liver fibrosis. Based on a histologic analysis, Kallwitz et al. [8] reported that obese OSAHS patients were more likely to develop fatty liver hepatitis and liver fibrosis when compared with obese patients. Among patients with obesity, more severe OSAHS was associated with more severe fatty liver hepatitis and liver fibrosis [9] . Tatsumi et al. [10] reported in a non-obese OSAHS patients-focused study, that in spite of a similar incidence of simple fatty liver between the OSAHS and non-OSAHS patients, the level of PIIIP, which reflects fibrosis, was associated with the average blood oxygen saturation. Tatsumi et al. [10] believes that the average blood oxygen saturation is a risk factor for fatty liver hepatitis, and OSAHS is one of the mechanisms underlying liver fibrosis. Our research results showed that the lowest blood oxygen saturation and the average blood oxygen saturation were closely associated with liver fibrosis. Animal experiments have confirmed that chronic intermittent hypoxia is a risk factor [11, 12] for changing simple fatty liver into fatty liver hepatitis. In addition, the "twohit hypothesis" suggests that intermittent hyoxemia in OSAHS patients can further prompt transformation from fatty liver to fatty liver hepatitis, which develops into liver fibrosis [13, 14] .
In summary, OSAHS patients might develop liver damage or even liver fibrosis due to insulin resistance [15] , nocturnal intermittent hypoxia, and oxidative stress. The explicit mechanism for liver fibrosis caused by OSAHS is not clear. In obese and non-obese patients with OSAHS, determination of the levels of serum HA, PIII, IVC, and LN can help identify damage early to facilitate the timely treatment of primary diseases and to reduce the incidence of liver fibrosis and to improve the prognosis of OSAHS patients. In addition, we plan to conduct experiments with color Doppler ultrasound and CT to further prove the relationship between OSAHS and liver fibrosis.
